Advanced feeder-free generation of induced pluri potent stem cells directly from blood cells

Stem Cells Translational Medicine

Volumn 3, Issue 12, 2014, Pages 1402-1409

  Trokovic, Ras ^a   Weltner, Jere ^a   Nishimura, Ken ^b   Ohtaka, Manami ^b   Nakanishi, Mahito ^b   Salomaa, Veikko ^c   Jalanko, Anu ^c   Otonkoski, Timo ^a,d   Kyttälä, Aija ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cell banking; Induced pluri potent stem cells; Nuclear reprogramming; Sendai virus

Indexed keywords

CELL MARKER; COLLAGEN TYPE 4; DEOXYRIBONUCLEASE I; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MITOMYCIN; OCTAMER TRANSCRIPTION FACTOR 4; REX PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 4; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR NANOG;

ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYOID BODY; GEL ELECTROPHORESIS; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOLONEY LEUKEMIA ONCOVIRUS; NUCLEAR REPROGRAMMING; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; CLINICAL TRIAL; CYTOLOGY; FEMALE; FINLAND; GENE VECTOR; MALE; METABOLISM; MONONUCLEAR CELL;

SENDAI VIRUS;

FEMALE; FINLAND; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 84913525327     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0113     Document Type: Article

References (33)

1. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluri potent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861–872.
2. Takahashi K, Yamanaka S. Induction of plu-ripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–676.
3. Okita K, Nakagawa M, Hyenjong H et al. Generation of mouse induced pluri potent stem cells without viral vectors. Science 2008;322: 949–953.
4. Yu J, Hu K, Smuga-Otto K et al. Human induced pluri potent stem cells free of vector and trans gene sequences. Science 2009;324:797–801.
5. Weltner J, Anisimov A, Alitalo K et al. Induced pluri potent stem cell clones reprog-rammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences. J Virol 2012;86:4463–4467.
6. Fusaki N, Ban H, Nishiyama A et al. Efficient induction of transgene-free human pluri potent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009;85:348–362.
7. Nishimura K, Sano M, Ohtaka M et al. Development of defective and persistent Sendai virus vector: A unique gene delivery/ expression system ideal for cell reprogram-ming. J Biol Chem 2011;286:4760–4771.
8. Loh YH, Hartung O, Li H et al. Reprogram-ming of T cells from human peripheral blood. Cell Stem Cell 2010;7:15–19.
9. Seki T, Yuasa S, Fukuda K. Generationofin-duced pluri potent stem cells from a small amountofhuman peripheral bloodusingacom-bination of activated T cells and Sendai virus. Nat Protoc 2012;7:718–728.
10. Seki T, Yuasa S, Oda M et al. Generation of induced pluri potent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010;7:11–14.
11. Staerk J, Dawlaty MM, Gao Q et al. Reprogramming of human peripheral blood cells to induced pluri potent stem cells. Cell Stem Cell 2010;7:20–24.
12. Trokovic R, Weltner J, Manninen T et al. Small molecule inhibitors promote efficient generation of induced pluri potent stem cells from human skeletal myoblasts. Stem Cells Dev 2013;22:114–123.
13. Okita K, Yamakawa T, Matsumura Y et al. An efficient nonviral method to generate integration-free human-induced pluri potent stemcellsfrom cord bloodandperipheralblood cells. Stem Cells 2013;31:458–466.
14. Dowey SN, Huang X, Chou BK et al. Generation of integration-free human induced plu-ripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc 2012;7:2013–2021.
15. Su RJ, Baylink DJ, Neises A et al. Efficient generationofintegration-free iPS cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS One 2013;8:e64496.
16. Ye L, Muench MO, Fusaki N et al. Blood cell-derived induced pluri potent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Translational Medicine 2013;2:558–566.
17. Wakao H, Yoshikiyo K, Koshimizu U et al. Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. Cell Stem Cell 2013;12:546–558.
18. Nishimura T, Kaneko S, Kawana-Tachi-kawa A et al. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 2013;12:114–126.
19. Vartiainen E, Laatikainen T, Peltonen M et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39:504–518.
20. Nakanishi M, Otsu M. Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr Gene Ther 2012;12:410–416.
21. Mali P, Chou BK, Yen J et al. Butyrate greatly enhances derivation of human induced pluri potent stem cells by promoting epigenetic remodeling and the expression ofpluripotency-associated genes. Stem Cells 2010;28:713–720.
22. Müller FJ, Schuldt BM, Williams R et al. A bioinformatic assay for pluripotency in human cells. Nat Methods 2011;8:315–317.
23. Okita K, Yamanaka S. Inducedpluri potent stem cells: Opportunities and challenges. Philos Trans R Soc Lond B Biol Sci 2011;366: 2198–2207.
24. Toivonen S, Ojala M, Hyysalo A et al. Comparative analysis of targeted differentiation of human induced pluri potent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencinginretrovirally derived hiPSC lines. Stem Cells Translational Medicine 2013;2: 83–93.
25. Connolly JB. Lentivirusesin gene therapy clinical research. Gene Ther 2002;9:1730–1734.
26. Kawamura T, Suzuki J, Wang YV et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 460:1140–1144.
27. Hong H, Takahashi K, Ichisaka T et al. Sup-pressionofinducedpluri potent stem cellgener-ation by the p53-p21 pathway. Nature 2009; 460:1132–1135.
28. González F, Georgieva D, Vanoli F et al. Homologous recombination DNA repair genes playa critical role inreprogrammingtoa plurip-otent state. Cell Reports 2013;3:651–660.
29. Okita K, Matsumura Y, Sato Y et al. Amore efficient method to generate integration-free human iPS cells. Nat Methods 2011;8:409–412.
30. Kawagoe S, Higuchi T, Otaka M et al. Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp). Mol Genet Metab 2013;109: 386–389.
31. Watabe A, Yamaguchi T, Kawanishi T et al. Target-cell specificity of fusogenic lipo-somes: Membrane fusion-mediated macromol-ecule delivery into human blood mononuclear cells. Biochim Biophys Acta 1999;1416:339–348.
32. Eguchi A, Kondoh T, Kosaka H et al. Identification and characterization of cell lines with a defect in a post-adsorption stage of Sendai virus-mediated membrane fusion. J Biol Chem 2000;275:17549–17555.
33. Tan HK, Toh CX, Ma D et al. Humanfinger-prick induced pluri potent stem cells facilitate the development of stem cell banking. Stem Cells Translational Medicine 2014;3:586–598.